Upgrade to SI Premium - Free Trial

Evoke Pharma (EVOK) Tops Q4 EPS by 8c

March 10, 2016 4:39 PM

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.37), $0.08 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

Categories

Earnings

Next Articles